Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000600278 | SCV000731801 | likely benign | not specified | 2017-08-30 | criteria provided, single submitter | clinical testing | p.Val233Ala in exon 37 of USH2A: This variant is not expected to have clinical s ignificance because it has been identified in 0.46% (87/18850) of East Asian chr omosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitut e.org/; dbSNP rs144817385). |
Labcorp Genetics |
RCV000907403 | SCV001052106 | likely benign | not provided | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Blueprint Genetics | RCV001075375 | SCV001240996 | uncertain significance | Retinal dystrophy | 2018-06-12 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000907403 | SCV001781721 | uncertain significance | not provided | 2021-08-05 | criteria provided, single submitter | clinical testing | Identified with other USH2A variants in individuals with hearing loss and/or retinitis pigmentosa in published literature (Sun et al., 2018; Ng et al., 2019; Xu et al., 2014; Yuan Y et al., 2020); In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 31541171, 31054281, 29625443, 24938718, 30948794) |
Institute of Human Genetics, |
RCV001075375 | SCV005071180 | uncertain significance | Retinal dystrophy | 2019-01-01 | criteria provided, single submitter | clinical testing | |
Laboratory of Diagnostic Genome Analysis, |
RCV000907403 | SCV002036442 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000907403 | SCV002037815 | uncertain significance | not provided | no assertion criteria provided | clinical testing |